Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA approves Kyleena for prevention of pregnancy for up to 5 years

Sep. 20, 2016

Weekly somapacitan appears more convenient than daily human growth hormone in phase III trial

Sep. 19, 2016

GX-H9 shows potential for the treatment of AGHD

Sep. 19, 2016

NBAS mutations may cause new syndrome associated with type 1 diabetes

Sep. 19, 2016

EMA committee recommends approval of Parsabiv in E.U.

Sep. 19, 2016

Novel mutations found that may cause Wolcott-Rallison syndrome

Sep. 19, 2016

EMA's CHMP recommends approval of Glyxambi for adults with type 2 diabetes

Sep. 19, 2016

Inhibition of midkine as promising new therapeutic strategy to enhance osteoporotic fracture healing

Sep. 19, 2016

Gene Techno Science initiates phase III trial of darbepoetin alfa biosimilar in Japan

Sep. 16, 2016

Liraglutide may exert epigenetic effect in T2DM patients

Sep. 16, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...